Skip to content
Home
Our Science
Pipeline & Assets
Team & Investors
Careers
News & Resources
Connect
News
& Resources
Featured Stories
Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage
Read More
GlobeNewswire
Siren Biotechnology Publishes Foundational AAV Immuno-Gene Therapy Data and Announces Presentations at ASGCT 2026
Read More
Siren Biotechnology Receives FDA Fast Track Designation for SRN-101 for the Treatment of Recurrent High-Grade Glioma
Read More
News
Patient Resources
Videos
Publications & Presentations
All
Media Coverage
Press Releases
Media Coverage
|
Posted on 3.1.24
Webinar – Undoing the Dogma: A Changing Ethos in AAV Gene Therapy Manufacturing
Read More
Media Coverage
|
Posted on 2.6.24
Exploring the frontiers of gene therapy and AAVs
Read More
Media Coverage
|
Posted on 12.4.23
The comparability tales: A phase-appropriate roadmap for CGT drug product development
Read More
Media Coverage
|
Posted on 11.9.23
Webinar – Proactive Strategies for Biotech Success in the 2024 Landscape
Read More
Media Coverage
|
Posted on 10.4.23
2023 All-In Summit – A discussion on the future of gene therapy
Read More
Media Coverage
|
Posted on 9.13.23
Webinar – The State of Biotech 2023
Read More
Media Coverage
|
Posted on 8.24.23
Developing universal AAV immuno-gene therapy for oncology
Read More
Media Coverage
|
Posted on 5.18.23
New biotech Siren calls for gene therapy and cancer to ‘get into the weeds together’
Read More
Media Coverage
|
Posted on 5.17.23
Siren emerges from stealth with plans to marry gene therapy to cancer immunotherapy
Read More
Media Coverage
|
Posted on 5.17.23
Nicole Paulk’s Siren Bio is building a gene therapy delivery vehicle against cancer
Read More
1
2
3
4
